Published in Infect Immun on August 01, 1996
Infection of human endothelial cells with Staphylococcus aureus induces the production of monocyte chemotactic protein-1 (MCP-1) and monocyte chemotaxis. Clin Exp Immunol (1999) 0.93
Nanoparticle mediated drug delivery of rolipram to tyrosine kinase B positive cells in the inner ear with targeting peptides and agonistic antibodies. Front Aging Neurosci (2015) 0.81
Regulation of complement C3 and C4 synthesis in human peritoneal mesothelial cells by peritoneal dialysis fluid. Clin Exp Immunol (2004) 0.80
Bacteria-derived DNA fragment in peritoneal dialysis effluent as a predictor of relapsing peritonitis. Clin J Am Soc Nephrol (2013) 0.76
The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell (1982) 4.17
Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med (1992) 2.15
Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. Immunology (1992) 1.93
Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int (1990) 1.71
Expression and secretion of gro/MGSA by stimulated human endothelial cells. EMBO J (1989) 1.70
Ingestion of Staphylococcus aureus by bovine endothelial cells results in time- and inoculum-dependent damage to endothelial cell monolayers. Infect Immun (1987) 1.55
Antibody-cell interactions: Fc receptors. Cell (1989) 1.41
Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant (1995) 1.32
Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha. Am J Pathol (1993) 1.21
Characterization of dendritic cells, isolated from normal and stimulated lymph nodes of the rat. Cell Tissue Res (1985) 1.05
Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis. J Infect Dis (1993) 1.02
The mesothelial cells in CAPD effluent and their relation to peritonitis incidence. Perit Dial Int (1991) 0.96
Antioxidant defense mechanisms in cultured pleural mesothelial cells. Am J Respir Cell Mol Biol (1992) 0.96
Interleukin-8 production by human mesothelial cells after direct stimulation with staphylococci. Infect Immun (1995) 0.94
Expression of the cysteine proteinase inhibitor cystatin C mRNA in rat eye. Anat Rec (1994) 0.91
Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int Suppl (1994) 0.87
Peritoneal host defense mechanisms in peritoneal dialysis. Kidney Int Suppl (1994) 0.86
Nitric oxide synthesis by rat pleural mesothelial cells: induction by cytokines and lipopolysaccharide. Am J Physiol (1993) 0.79
Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol (2004) 6.47
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet (1999) 3.25
Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med (1989) 2.94
Lack of specific renal haemodynamic effects of different doses of dopamine after infrarenal aortic surgery. Br J Anaesth (1996) 2.67
Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet (1997) 2.60
Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int (2007) 2.42
Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain (2003) 2.37
Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. Am J Kidney Dis (1997) 2.37
A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. J Immunol Methods (1994) 2.06
Physical symptoms and quality of life in patients on chronic dialysis: results of The Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD) Nephrol Dial Transplant (1999) 2.04
Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg (1998) 2.02
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta (2002) 1.98
Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology (1999) 1.84
Validation of the KDQOL-SF: a dialysis-targeted health measure. Qual Life Res (2002) 1.79
Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. Am J Pathol (1999) 1.75
Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J Lab Clin Med (1999) 1.71
Heterogeneity of macrophages in the rat evidenced by variability in determinants: two new anti-rat macrophage antibodies against a heterodimer of 160 and 95 kd (CD11/CD18). J Leukoc Biol (1989) 1.65
The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer. Surgery (2000) 1.61
Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin. J Clin Oncol (2000) 1.60
Regulation of CD 163 on human macrophages: cross-linking of CD163 induces signaling and activation. J Leukoc Biol (1999) 1.59
A comparison of three methods for nonpalpable breast cancer excision. Eur J Surg Oncol (2010) 1.59
New horizons in colorectal cancer surgery. Surg Endosc (2008) 1.55
Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med (1993) 1.55
Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet (1984) 1.53
Circadian rhythm of glomerular filtration rate in normal individuals. Clin Sci (Lond) (1989) 1.53
Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography. Ann Surg (1999) 1.49
The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival. Perit Dial Int (1994) 1.48
When to initiate dialysis: effect of proposed US guidelines on survival. Lancet (2001) 1.47
Practical guidelines for the use of NESP in treating renal anaemia. Nephrol Dial Transplant (2001) 1.47
Role of omental milky spots in the local immune response. Lancet (1992) 1.45
Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int (2000) 1.44
Successful surgical treatment of parathyroid carcinoma in two haemodialysis patients. Nephrol Dial Transplant (1990) 1.43
Localization of regional lymph nodes in melanomas of the head and neck. Arch Otolaryngol Head Neck Surg (1998) 1.43
[The historical perspective of the sentinel lymph node concept]. Ned Tijdschr Geneeskd (2008) 1.42
Effect of electric charge on the transperitoneal transport of plasma proteins during CAPD. Nephrol Dial Transplant (1996) 1.41
Indirect measurement of lymphatic absorption with inulin in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int (1990) 1.40
Kupffer cell depletion by CI2MDP-liposomes alters hepatic cytokine expression and delays liver regeneration after partial hepatectomy. Liver (2000) 1.39
Unimpaired immune functions after laparoscopic cholecystectomy. Surgery (1994) 1.39
Predialytic period and baseline peritoneal membrane status: any connection? Perit Dial Int (2010) 1.39
[Breast self-examination also valuable in women participating in a screening programme]. Ned Tijdschr Geneeskd (2008) 1.39
Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells. Kidney Int (1998) 1.38
Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Perit Dial Int (1997) 1.37
T cell priming in situ by intratracheally instilled antigen-pulsed dendritic cells. Am J Respir Cell Mol Biol (1993) 1.35
Intraperitoneal administration of recombinant human erythropoietin. Perit Dial Int (1992) 1.34
Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg (2001) 1.34
Acute and cumulative effects of carboplatin on renal function. Br J Cancer (1989) 1.33
Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant (1995) 1.32
Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg (1994) 1.27
Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Ann Surg (2000) 1.27
Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol (2002) 1.27
Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med (1997) 1.25
Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol (1996) 1.25
The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma. Cancer (2001) 1.25
Predicting mortality in intensive care patients with acute renal failure treated with dialysis. J Am Soc Nephrol (1997) 1.25
Acute interstitial nephritis: a clinical and morphological study in 27 patients. Nephrol Dial Transplant (1990) 1.23
5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers. Ann Oncol (2004) 1.23
Cellular composition of milky spots in the human greater omentum: an immunochemical and ultrastructural study. Anat Rec (1995) 1.23
Cardiac and hemodynamic effects of hemodialysis and ultrafiltration. Am J Kidney Dis (2000) 1.22
Mortality and technique failure in patients starting chronic peritoneal dialysis: results of The Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int (1999) 1.20
Identification of exudate-resident macrophages on the basis of peroxidatic activity. J Reticuloendothel Soc (1978) 1.19
Systemic and peritoneal inflammatory response after laparoscopic or conventional colon resection in cancer patients: a prospective, randomized trial. Dis Colon Rectum (2003) 1.18
Ultrastructure of mononuclear phagocytes developing in liquid bone marrow cultures. A study on peroxidatic activity. J Exp Med (1979) 1.17
Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil. J Clin Oncol (1994) 1.17
Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol (2001) 1.16
Migration of dendritic cells into the draining lymph nodes of the lung after intratracheal instillation. Am J Respir Cell Mol Biol (1993) 1.15
Lymph node negative colorectal cancers with isolated tumor deposits should be classified and treated as stage III. Ann Surg Oncol (2010) 1.15
The cellular composition of omentum milky spots and the ultrastructure of milky spot macrophages and reticulum cells. J Reticuloendothel Soc (1980) 1.14
Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence. Eur J Cancer (2011) 1.14
Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group. Am J Kidney Dis (2000) 1.13
Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrol Dial Transplant (1994) 1.13
Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology (1996) 1.12
Reliability of the 7-point subjective global assessment scale in assessing nutritional status of dialysis patients. Adv Perit Dial (1999) 1.12
Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours. Eur J Cancer (1996) 1.11
A circadian rhythm of proteinuria in patients with a nephrotic syndrome. Clin Sci (Lond) (1985) 1.11
Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells. Cancer Immunol Immunother (1993) 1.10
Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis. Perit Dial Int (1997) 1.09
Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinoma. Cancer (1983) 1.09
Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood (1996) 1.09
Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer. Eur J Cancer (2002) 1.09
Tumour lysis syndrome and acute renal failure in Burkitt's lymphoma. Description of 2 cases and a review of the literature on prevention and management. Neth J Med (1994) 1.08
Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. Kidney Int (2001) 1.07
Phase I and pharmacologic study of the novel indoloquinone bioreductive alkylating cytotoxic drug E09. J Natl Cancer Inst (1994) 1.07
Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. J Clin Oncol (2003) 1.06
Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. A methodological study. J Immunol Methods (1991) 1.06
Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Kidney Int (1994) 1.06
Immunological consequences of laparoscopic surgery, speculations on the cause and clinical implications. Langenbecks Arch Surg (1999) 1.05
Monoclonal antibody EBM11 (anti-CD68) discriminates between dendritic cells and macrophages after short-term culture. Immunobiology (1991) 1.04
Rat bone marrow and monocyte cultures: influence of culture time and lymphokines on the expression of macrophage differentiation antigens. J Leukoc Biol (1989) 1.04
Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int (1996) 1.04
Quality of life over time in dialysis: the Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int (1999) 1.03
Changes in employment status in end-stage renal disease patients during their first year of dialysis. Perit Dial Int (2002) 1.03
4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodes. Clin Immunol (2010) 1.03
Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention. Br J Radiol (2010) 1.03
The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int (1995) 1.03
Chemokines produced by mesothelial cells: huGRO-alpha, IP-10, MCP-1 and RANTES. Clin Exp Immunol (1998) 1.03